These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24392393)

  • 1. A study of efficacy of ormeloxifene in the pharmacological management of dysfunctional uterine bleeding.
    Ravibabu K; Palla J; Chintada GS
    J Clin Diagn Res; 2013 Nov; 7(11):2534-6. PubMed ID: 24392393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of sevista in the management of dysfunctional uterine bleeding.
    Bs D; Nanda SK
    J Clin Diagn Res; 2013 Jan; 7(1):132-4. PubMed ID: 23450207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Safety and Efficacy of Ormeloxifene, a Selective Estrogen Receptor Modulator and Medroxyprogesterone Acetate in Women with Non-Structural Abnormal Uterine Bleeding: A Randomized Clinical Trial.
    Mir SA; Ara R; Amin F; Malik A; Hamid L; Ali T; Bader GN; Wani SUD; Almuqbil M; Alshehri S; Alshehri AM; Shakeel F
    Medicina (Kaunas); 2022 Oct; 58(11):. PubMed ID: 36363460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Study of Ormeloxifene and Medroxyprogesterone Acetate in Abnormal Uterine Bleeding.
    Godha Z; Mohsin Z; Hakim S; Wasim S
    J Obstet Gynaecol India; 2016 Oct; 66(Suppl 1):395-9. PubMed ID: 27651636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of ormeloxifene versus oral contraceptive in the management of abnormal uterine bleeding due to uterine leiomyoma.
    Kriplani A; Srivastava A; Kulshrestha V; Kachhawa G; Agarwal N; Bhatla N; Hari S
    J Obstet Gynaecol Res; 2016 Dec; 42(12):1744-1752. PubMed ID: 27647770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial comparing the Cavaterm endometrial ablation system with the Nd:YAG laser for the treatment of dysfunctional uterine bleeding.
    Hawe J; Abbott J; Hunter D; Phillips G; Garry R
    BJOG; 2003 Apr; 110(4):350-7. PubMed ID: 12699795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysfunctional uterine bleeding in ovulatory women.
    Strickler RC
    Postgrad Med; 1985 Jan; 77(1):235-7, 240-3, 246. PubMed ID: 3880890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
    Barlow DH; Lumsden MA; Fauser BC; Terrill P; Bestel E
    Hum Reprod; 2014 Mar; 29(3):480-9. PubMed ID: 24457604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
    Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
    Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ormeloxifene - Looking beyond contraception.
    Pati T; Chanania K; Marandi S; Hansa J
    J Midlife Health; 2017; 8(1):17-20. PubMed ID: 28458475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of a non-hormonal oral anti-fibrinolytic hemostatic agent (tranexamic acid) for management of patients with dysfunctional uterine bleeding.
    Gultekin M; Diribaş K; Buru E; Gökçeoğlu MA
    Clin Exp Obstet Gynecol; 2009; 36(3):163-5. PubMed ID: 19860359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered uterine artery blood flow impedance after danazol therapy: possible mode of action in dysfunctional uterine bleeding.
    Pepper J; Dewart PJ; Oyesanya OA
    Fertil Steril; 1999 Jul; 72(1):66-70. PubMed ID: 10428150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of abnormal uterine bleeding.
    Chuong CJ; Brenner PF
    Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 2):787-92. PubMed ID: 8828563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term effect on radiofrequency heat-coagulation endometrial ablation in the treatment of anovulatory dysfunctional uterine bleeding].
    Yin GP; Li J; Zhu TY; Chen M; Yang SJ; Zhao XL
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):664-8. PubMed ID: 22176990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro anti-resorptive activity and prevention of ovariectomy-induced osteoporosis in female Sprague-Dawley rats by ormeloxifene, a selective estrogen receptor modulator.
    Arshad M; Sengupta S; Sharma S; Ghosh R; Sawlani V; Singh MM
    J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):67-78. PubMed ID: 15261309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of mechanisms underlying disturbances of bleeding caused by spontaneous dysfunctional uterine bleeding or hormonal contraception.
    Fraser IS; Hickey M; Song JY
    Hum Reprod; 1996 Oct; 11 Suppl 2():165-78. PubMed ID: 8982758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding.
    Pinion SB; Parkin DE; Abramovich DR; Naji A; Alexander DA; Russell IT; Kitchener HC
    BMJ; 1994 Oct; 309(6960):979-83. PubMed ID: 7772106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Goserelin acetate (Zoladex) plus endometrial ablation for dysfunctional uterine bleeding: a large randomized, double-blind study.
    Donnez J; Vilos G; Gannon MJ; Stampe-Sorensen S; Klinte I; Miller RM
    Fertil Steril; 1997 Jul; 68(1):29-36. PubMed ID: 9207580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective estrogen receptor modulator ormeloxifene suppresses embryo implantation via inducing miR-140 and targeting insulin-like growth factor 1 receptor in rat uterus.
    Sirohi VK; Gupta K; Kumar R; Shukla V; Dwivedi A
    J Steroid Biochem Mol Biol; 2018 Apr; 178():272-282. PubMed ID: 29330027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby AE; Cooke I; Rees M
    Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.